Long-Term Treatment with Bulevirtide in Patients with Chronic Hepatitis D and Advanced Chronic Liver Disease

Long-Term Treatment with Bulevirtide in Patients with Chronic Hepatitis D and Advanced Chronic Liver Disease

Bulevirtide (BLV) is approved for the treatment of chronic hepatitis D (CHD). Because only limited long-term experience has been reported, we aimed to evaluate the efficacy and safety of BLV treatment in patients with advanced chronic liver disease (ACLD). We performed a retrospective analysis of pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayaz Sapuk, Leonie Steinhoff, Kristin Hünninghaus, Katharina Willuweit, Jassin Rashidi Alavijeh, Benedikt Hild, Lucia Asar, Hartmut H. Schmidt, Christoph Schramm
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2024/2364031
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items